Sinteca Bio has ranked among the top searched stocks on 9 days within the past month.


As of 9:30 AM on the 5th, Sinteca Bio is trading at 36,450 KRW, down 6.3% from the previous day. This represents a 151.38% increase compared to September 2. Sinteca Bio is known as a genomic big data research company.

Over the past 5 days, individual investors have net purchased 57,640 shares, while foreigners and institutions have net sold 59,425 shares and net purchased 2,690 shares, respectively.


On September 29, Sinteca Bio became a market issue with the headline "COVID-19 treatment efficacy Remdesivir doubled, hitting the upper price limit."



※Source: AI Investment Assistant AI Rasero


※ This article was generated in real-time by an article automation algorithm jointly developed by Asia Economy and financial AI specialist company Thinkpool.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing